Your browser doesn't support javascript.
loading
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Solomonidou, Nantia; Germanou, Daphnie; Strouthos, Iosif; Karagiannis, Efstratios; Farolfi, Andrea; Koerber, Stefan A; Debus, Juergen; Peeken, Jan C; Vogel, Marco E; Vrachimis, Alexis; Spohn, Simon K B; Shelan, Mohamed; Aebersold, Daniel; Grosu, Anca-Ligia; Ceci, Francesco; Kroeze, Stephanie G C; Guckenberger, Matthias; Fanti, Stefano; Belka, Claus; Hruby, George; Scharl, S; Wiegel, Thomas; Bartenstein, Peter; Henkenberens, Christoph; Emmett, Louise; Schmidt-Hegemann, Nina Sophie; Ferentinos, Konstantinos; Zamboglou, Constantinos.
Afiliação
  • Solomonidou N; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Germanou D; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Karagiannis E; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Peeken JC; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Vogel ME; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Vrachimis A; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Spohn SKB; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.
  • Shelan M; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
  • Aebersold D; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
  • Grosu AL; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.
  • Ceci F; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
  • Kroeze SGC; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Guckenberger M; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus.
  • Fanti S; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Belka C; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.
  • Hruby G; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Scharl S; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Wiegel T; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Bartenstein P; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Henkenberens C; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.
  • Emmett L; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Schmidt-Hegemann NS; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Ferentinos K; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Zamboglou C; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Eur J Nucl Med Mol Imaging ; 50(8): 2529-2536, 2023 07.
Article em En | MEDLINE | ID: mdl-36905411
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Chipre
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Clinical_trials / Guideline / Observational_studies Limite: Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Chipre